Stem cell-based therapy for ischemic heart disease

Cell Transplantation

Volumn 22, Issue 4, 2013, Pages 663-675

  Hsiao, Lien Cheng ^a,b   Carr, Carolyn ^a   Chang, Kuan Cheng ^b   Lin, Shinn Zong ^b,c,d   Clarke, Kieran ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cardiac tissue engineering (CTE); Cell transplantation; Heart failure (HF); Ischemic heart disease (IHD); Stem cell

Indexed keywords

ALGINIC ACID; CD133 ANTIGEN; CD34 ANTIGEN; COLLAGEN; GELATIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POLYLACTIC ACID; STEM CELL ANTIGEN 1; STEM CELL FACTOR RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ACUTE HEART INFARCTION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CARDIAC STEM CELL; CORONARY ARTERY BYPASS GRAFT; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; FOLLOW UP; HEART FAILURE; HUMAN; ISCHEMIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; MYOBLAST; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; HUMANS; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING;

EID: 84876704672     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X655109     Document Type: Review

References (133)

1. Abdel-Latif, A.; Bolli, R.; Tleyjeh, I. M.; Montori, V. M.; Perin, E. C.; Hornung, C. A.; Zuba-Surma, E. K.; Al-Mallah, M.; Dawn, B. Adult bone marrow-derived cells for cardiac repair: A systematic review and metaanalysis. Arch. Intern. Med. 167(10):989-997; 2007.
2. Abkowitz, J. L.; Catlin, S. N.; McCallie, M. T.; Guttorp, P. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 100(7):2665-2667; 2002.
3. Akhyari, P.; Kamiya, H.; Haverich, A.; Karck, M.; Lichtenberg, A. Myocardial tissue engineering: The extracellular matrix. Eur. J. Cardiothorac. Surg. 34(2): 229-241; 2008.
4. Amado, L. C.; Saliaris, A. P.; Schuleri, K. H.; St John, M.; Xie, J. S.; Cattaneo, S.; Durand, D. J.; Fitton, T.; Kuang, J. Q.; Stewart, G.; Lehrke, S.; Baumgartner, W. W.; Martin, B. J.; Heldman, A. W.; Hare, J. M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102(32):11474-11479; 2005.
5. Balsam, L. B.; Wagers, A. J.; Christensen, J. L.; Kofidis, T.; Weissman, I. L.; Robbins, R. C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983):668-673; 2004.
6. Bearzi, C.; Rota, M.; Hosoda, T.; Tillmanns, J.; Nascimbene, A.; De Angelis, A.; Yasuzawa-Amano, S.; Trofimova, I.; Siggins, R. W.; Lecapitaine, N.; Cascapera, S.; Beltrami, A. P.; D'Alessandro, D. A.; Zias, E.; Quaini, F.; Urbanek, K.; Michler, R. E.; Bolli, R.; Kajstura, J.; Leri, A.; Anversa, P. Human cardiac stem cells. Proc. Natl. Acad. Sci. USA 104(35):14068-14073; 2007.
7. Behfar, A.; Yamada, S.; Crespo-Diaz, R.; Nesbitt, J. J.; Rowe, L. A.; Perez-Terzic, C.; Gaussin, V.; Homsy, C.; Bartunek, J.; Terzic, A. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. 56(9):721-734; 2010.
8. Beltrami, A. P.; Barlucchi, L.; Torella, D.; Baker, M.; Limana, F.; Chimenti, S.; Kasahara, H.; Rota, M.; Musso, E.; Urbanek, K.; Leri, A.; Kajstura, J.; Nadal-Ginard, B.; Anversa, P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114(6):763-776; 2003.
9. Bolli, R.; Chugh, A. R.; D'Amario, D.; Loughran, J. H.; Stoddard, M. F.; Ikram, S.; Beache, G. M.; Wagner, S. G.; Leri, A.; Hosoda, T.; Sanada, F.; Elmore, J. B.; Goichberg, P.; Cappetta, D.; Solankhi, N. K.; Fahsah, I.; Rokosh, D. G.; Slaughter, M. S.; Kajstura, J.; Anversa, P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 378(9806):1847-1857; 2011.
10. Boyle, A. J.; Schulman, S. P.; Hare, J. M.; Oettgen, P. Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step. Circulation 114(4):339-352; 2006.
11. Bradley, A.; Evans, M.; Kaufman, M. H.; Robertson, E. Formation of germ-line chimaeras from embryoderived teratocarcinoma cell lines. Nature 309(5965): 255-256; 1984.
12. Breitbach, M.; Bostani, T.; Roell, W.; Xia, Y.; Dewald, O.; Nygren, J. M.; Fries, J. W.; Tiemann, K.; Bohlen, H.; Hescheler, J.; Welz, A.; Bloch, W.; Jacobsen, S. E.; Fleischmann, B. K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110(4):1362-1369; 2007.
13. Buckberg, G. D. Basic science review: The helix and the heart. J. Thorac. Cardiovasc. Surg. 124(5):863-883; 2002.
14. Byun, K. H.; Kim, S. W. Is stem cell-based therapy going on or out for cardiac disease? Korean Circ. J. 39(3):87-92; 2009.
15. Caplan, A. I.; Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98(5):1076-1084; 2006.
16. Caspi, O.; Lesman, A.; Basevitch, Y.; Gepstein, A.; Arbel, G.; Habib, I. H.; Gepstein, L.; Levenberg, S. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100(2):263-272; 2007.
17. Chen, S. L.; Fang, W. W.; Ye, F.; Liu, Y. H.; Qian, J.; Shan, S. J.; Zhang, J. J.; Chunhua, R. Z.; Liao, L. M.; Lin, S.; Sun, J. P. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94(1):92-95; 2004.
18. Chin, M. H.; Mason, M. J.; Xie, W.; Volinia, S.; Singer, M.; Peterson, C.; Ambartsumyan, G.; Aimiuwu, O.; Richter, L.; Zhang, J.; Khvorostov, I.; Ott, V.; Grunstein, M.; Lavon, N.; Benvenisty, N.; Croce, C. M.; Clark, A. T.; Baxter, T.; Pyle, A. D.; Teitell, M. A.; Pelegrini, M.; Plath, K.; Lowry, W. E. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5(1):111-123; 2009.
19. Christman, K. L.; Vardanian, A. J.; Fang, Q.; Sievers, R. E.; Fok, H. H.; Lee, R. J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44(3):654-660; 2004.
20. Codina, M.; Elser, J.; Margulies, K. B. Current status of stem cell therapy in heart failure. Curr. Cardiol. Rep. 12(3):199-208; 2010.
21. Courtman, D. W.; Pereira, C. A.; Kashef, V.; McComb, D.; Lee, J. M.; Wilson, G. J. Development of a pericardial acellular matrix biomaterial: Biochemical and mechanical effects of cell extraction. J. Biomed. Mater. Res. 28(6):655-666; 1994.
22. Dai, W.; Wold, L. E.; Dow, J. S.; Kloner, R. A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: A novel approach to preserve cardiac function after myocardial infarction. J. Am. Coll. Cardiol. 46(4):714-719; 2005.
23. Davis, D. R.; Smith, R. R.; Marban, E. Human Cardiospheres are a Source of Stem Cells with Cardiomyogenic Potential. Stem Cells 28(5):903-904; 2010.
24. Davis, D. R.; Zhang, Y.; Smith, R. R.; Cheng, K.; Terrovitis, J.; Malliaras, K.; Li, T. S.; White, A.; Makkar, R.; Marban, E. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 4(9):e7195; 2009.
25. Davis, M. E.; Motion, J. P.; Narmoneva, D. A.; Takahashi, T.; Hakuno, D.; Kamm, R. D.; Zhang, S.; Lee, R. T. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 111(4):442-450; 2005.
26. Deisher, T. A. Cardiac-derived stem cells. IDrugs 3(6): 649-653; 2000.
27. Dimmeler, S.; Zeiher, A. M. Cell therapy of acute myocardial infarction: Open questions. Cardiology 113(3):155-160; 2009.
28. Dowell, J. D.; Rubart, M.; Pasumarthi, K. B.; Soonpaa, M. H.; Field, L. J. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc. Res. 58(2):336-350; 2003.
29. Duckers, H. J.; Houtgraaf, J.; Hehrlein, C.; Schofer, J.; Waltenberger, J.; Gershlick, A.; Bartunek, J.; Nienaber, C.; Macaya, C.; Peters, N.; Smits, P.; Siminiak, T.; van Mieghem, W.; Legrand, V.; Serruys, P. W. Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: The SEISMIC trial. EuroIntervention 6(7): 805-812; 2011.
30. Eschenhagen, T.; Fink, C.; Remmers, U.; Scholz, H.; Wattchow, J.; Weil, J.; Zimmermann, W.; Dohmen, H. H.; Schafer, H.; Bishopric, N.; Wakatsuki, T.; Elson, E. L. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: A new heart muscle model system. FASEB J. 11(8):683-694; 1997.
31. Evans, M. J.; Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292(5819):154-156; 1981.
32. Gerecht-Nir, S.; Radisic, M.; Park, H.; Cannizzaro, C.; Boublik, J.; Langer, R.; Vunjak-Novakovic, G. Biophysical regulation during cardiac development and application to tissue engineering. Int. J. Dev. Biol. 50(2-3): 233-243; 2006.
33. Gersh, B. J.; Simari, R. D.; Behfar, A.; Terzic, C. M.; Terzic, A. Cardiac cell repair therapy: A clinical perspective. Mayo Clin. Proc. 84(10):876-892; 2009.
34. Ghostine, S.; Carrion, C.; Souza, L. C.; Richard, P.; Bruneval, P.; Vilquin, J. T.; Pouzet, B.; Schwartz, K.; Menasche, P.; Hagege, A. A. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106(12 Suppl 1):I131-136; 2002.
35. Grabow, N.; Schmohl, K.; Khosravi, A.; Philipp, M.; Scharfschwerdt, M.; Graf, B.; Stamm, C.; Haubold, A.; Schmitz, K. P.; Steinhoff, G. Mechanical and structural properties of a novel hybrid heart valve scaffold for tissue engineering. Artif. Organs 28(11):971-979; 2004.
36. Hansson, E. M.; Lindsay, M. E.; Chien, K. R. Regeneration next: Toward heart stem cell therapeutics. Cell Stem Cell 5(4):364-377; 2009.
37. Hatzistergos, K. E.; Quevedo, H.; Oskouei, B. N.; Hu, Q.; Feigenbaum, G. S.; Margitich, I. S.; Mazhari, R.; Boyle, A. J.; Zambrano, J. P.; Rodriguez, J. E.; Dulce, R.; Pattany, P. M.; Valdes, D.; Revilla, C.; Heldman, A. W.; McNiece, I.; Hare, J. M. Bone Marrow Mesenchymal Stem Cells Stimulate Cardiac Stem Cell Proliferation and Differentiation. Circ. Res. 107(7):913-922; 2010.
38. Hellermann, J. P.; Jacobsen, S. J.; Redfield, M. M.; Reeder, G. S.; Weston, S. A.; Roger, V. L. Heart failure after myocardial infarction: Clinical presentation and survival. Eur. J. Heart Fail. 7(1):119-125; 2005.
39. Hou, D.; Youssef, E. A.; Brinton, T. J.; Zhang, P.; Rogers, P.; Price, E. T.; Yeung, A. C.; Johnstone, B. H.; Yock, P. G.; March, K. L. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: Implications for current clinical trials. Circulation 112(9 Suppl):I150-156; 2005.
40. Hu, X.; Yu, S. P.; Fraser, J. L.; Lu, Z.; Ogle, M. E.; Wang, J. A.; Wei, L. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thorac. Cardiovasc. Surg. 135(4):799-808; 2008.
41. Jain, M.; DerSimonian, H.; Brenner, D. A.; Ngoy, S.; Teller, P.; Edge, A. S.; Zawadzka, A.; Wetzel, K.; Sawyer, D. B.; Colucci, W. S.; Apstein, C. S.; Liao, R. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103(14):1920-1927; 2001.
42. Jawad, H.; Ali, N. N.; Lyon, A. R.; Chen, Q. Z.; Harding, S. E.; Boccaccini, A. R. Myocardial tissue engineering: A review. J. Tissue Eng. Regen. Med. 1(5):327-342; 2007.
43. Jawad, H.; Lyon, A. R.; Harding, S. E.; Ali, N. N.; Boccaccini, A. R. Myocardial tissue engineering. Br. Med. Bull. 87:31-47; 2008.
44. Johnston, P. V.; Sasano, T.; Mills, K.; Evers, R.; Lee, S. T.; Smith, R. R.; Lardo, A. C.; Lai, S.; Steenbergen, C.; Gerstenblith, G.; Lange, R.; Marbán, E. Engraftment, differentiation, and functional benefits of autologous cardiosphere- derived cells in porcine ischemic cardiomyopathy. Circulation 120(12):1075-1083; 2009.
45. Kim, D.; Kim, C. H.; Moon, J. I.; Chung, Y. G.; Chang, M. Y.; Han, B. S.; Ko, S.; Yang, E.; Cha, K. Y.; Lanza, R.; Kim, K. S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4(6):472-476; 2009.
46. Klug, M. G.; Soonpaa, M. H.; Koh, G. Y.; Field, L. J. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J. Clin. Invest. 98(1):216-224; 1996.
47. Kofidis, T.; Lebl, D. R.; Martinez, E. C.; Hoyt, G.; Tanaka, M.; Robbins, R. C. Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112(9 Suppl):I173-177; 2005.
48. Laflamme, M. A.; Chen, K. Y.; Naumova, A. V.; Muskheli, V.; Fugate, J. A.; Dupras, S. K.; Reinecke, H.; Xu, C.; Hassanipour, M.; Police, S.; O'Sullivan, C.; Collins, L.; Chen, Y.; Minami, E.; Gill, E. A.; Ueno, S.; Yuan, C.; Gold, J.; Murry, C. E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25(9):1015-1024; 2007.
49. Lainscak, M.; Coletta, A. P.; Sherwi, N.; Cleland, J. G. Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1. Eur. J. Heart Fail. 12(2):193-196; 2010.
50. Laugwitz, K. L.; Moretti, A.; Caron, L.; Nakano, A.; Chien, K. R. Islet1 cardiovascular progenitors: A single source for heart lineages? Development 135(2):193-205; 2008.
51. Leor, J.; Aboulafia-Etzion, S.; Dar, A.; Shapiro, L.; Barbash, I. M.; Battler, A.; Granot, Y.; Cohen, S. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 102(19 Suppl 3): III56-61; 2000.
52. Leor, J.; Amsalem, Y.; Cohen, S. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Ther. 105(2):151-163; 2005.
53. Leor, J.; Tuvia, S.; Guetta, V.; Manczur, F.; Castel, D.; Willenz, U.; Petnehazy, O.; Landa, N.; Feinberg, M. S.; Konen, E.; Goitein, O.; Tsur-Gang, O.; Shaul, M.; Klapper, L.; Cohen, S. Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine. J. Am. Coll. Cardiol. 54(11):1014-1023; 2009.
54. Li, S. C.; Wang, L.; Jiang, H.; Acevedo, J.; Chang, A. C.; Loudon, W. G. Stem cell engineering for treatment of heart diseases: Potentials and challenges. Cell Biol. Int. 33(3):255-267; 2009.
55. Li, W.; Ma, N.; Ong, L. L.; Nesselmann, C.; Klopsch, C.; Ladilov, Y.; Furlani, D.; Piechaczek, C.; Moebius, J. M.; Lutzow, K.; Lendlein, A.; Stamm, C.; Li, R. K.; Steinhoff, G. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25(8):2118-2127; 2007.
56. Limana, F.; Zacheo, A.; Mocini, D.; Mangoni, A.; Borsellino, G.; Diamantini, A.; De Mori, R.; Battistini, L.; Vigna, E.; Santini, M.; Loiaconi, V.; Pompilio, G.; Germani, A.; Capogrossi, M. C. Identification of myocardial and vascular precursor cells in human and mouse epicardium. Circ. Res. 101(12):1255-1265; 2007.
57. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; Hata, J.; Umezawa, A.; Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103(5):697-705; 1999.
58. Makkar, R. R.; Smith, R. R.; Cheng, K.; Malliaras, K.; Thomson, L. E.; Berman, D.; Czer, L. S.; Marban, L.; Mendizabal, A.; Johnston, P. V.; Russell, S. D.; Schuleri, K. H.; Lardo, A. C.; Gerstenblith, G.; Marbán, E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet 379(9819):895-904; 2012.
59. Malliaras, K.; Marban, E. Cardiac cell therapy: Where we've been, where we are, and where we should be headed. Br. Med. Bull. 98:161-185; 2011.
60. Mangi, A. A.; Noiseux, N.; Kong, D.; He, H.; Rezvani, M.; Ingwall, J. S.; Dzau, V. J. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9(9):1195-1201; 2003.
61. Marban, E.; Malliaras, K. Boot camp for mesenchymal stem cells. J. Am. Coll. Cardiol. 56(9):735-737; 2010.
62. Martin, C. M.; Meeson, A. P.; Robertson, S. M.; Hawke, T. J.; Richardson, J. A.; Bates, S.; Goetsch, S. C.; Gallardo, T. D.; Garry, D. J. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev. Biol. 265(1):262-275; 2004.
63. Martin-Puig, S.; Wang, Z.; Chien, K. R. Lives of a heart cell: Tracing the origins of cardiac progenitors. Cell Stem Cell 2(4):320-331; 2008.
64. Martinez, E. C.; Kofidis, T. Myocardial tissue engineering: The quest for the ideal myocardial substitute. Expert Rev. Cardiovasc. Ther. 7(8):921-928; 2009.
65. Masuda, S.; Shimizu, T.; Yamato, M.; Okano, T. Cell sheet engineering for heart tissue repair. Adv. Drug Deliv. Rev. 60(2):277-285; 2008.
66. Mauritz, C.; Schwanke, K.; Reppel, M.; Neef, S.; Katsirntaki, K.; Maier, L. S.; Nguemo, F.; Menke, S.; Haustein, M.; Hescheler, J.; Hasenfuss, G.; Martin, U. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118(5):507-517; 2008.
67. Menasche, P.; Alfieri, O.; Janssens, S.; McKenna, W.; Reichenspurner, H.; Trinquart, L.; Vilquin, J. T.; Marolleau, J. P.; Seymour, B.; Larghero, J.; Lake, S.; Chatellier, G.; Solomon, S.; Desnos, M.; Hagège, A. A. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 117(9):1189-1200; 2008.
68. Menasche, P.; Hagege, A. A.; Scorsin, M.; Pouzet, B.; Desnos, M.; Duboc, D.; Schwartz, K.; Vilquin, J. T.; Marolleau, J. P. Myoblast transplantation for heart failure. Lancet 357(9252):279-280; 2001.
69. Menasche, P.; Hagege, A. A.; Vilquin, J. T.; Desnos, M.; Abergel, E.; Pouzet, B.; Bel, A.; Sarateanu, S.; Scorsin, M.; Schwartz, K.; Bruneval, P.; Benbunan, M.; Marolleau, J. P.; Duboc, D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 1(7):1078-1083; 2003.
70. Messina, E.; De Angelis, L.; Frati, G.; Morrone, S.; Chimenti, S.; Fiordaliso, F.; Salio, M.; Battaglia, M.; Latronico, M. V.; Coletta, M.; Vivarelli, E.; Frati, L.; Cossu, G.; Giacomello, A. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 95(9):911-921; 2004.
71. Min, J. Y.; Yang, Y.; Converso, K. L.; Liu, L.; Huang, Q.; Morgan, J. P.; Xiao, Y. F. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92(1):288-296; 2002.
72. Miyahara, Y.; Nagaya, N.; Kataoka, M.; Yanagawa, B.; Tanaka, K.; Hao, H.; Ishino, K.; Ishida, H.; Shimizu, T.; Kangawa, K.; Sano, S.; Okano, T.; Kitamura, S.; Mori, H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12(4): 459-465; 2006.
73. Morritt, A. N.; Bortolotto, S. K.; Dilley, R. J.; Han, X.; Kompa, A. R.; McCombe, D.; Wright, C. E.; Itescu, S.; Angus, J. A.; Morrison, W. A. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115(3):353-360; 2007.
74. Murry, C. E.; Field, L. J.; Menasche, P. Cell-based cardiac repair: Reflections at the 10-year point. Circulation 112(20):3174-3183; 2005.
75. Murry, C. E.; Soonpaa, M. H.; Reinecke, H.; Nakajima, H.; Nakajima, H. O.; Rubart, M.; Pasumarthi, K. B.; Virag, J. I.; Bartelmez, S. H.; Poppa, V.; Bradford, G.; Dowell, J. D.; Williams, D. A.; Field, L. J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983):664-668; 2004.
76. Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Okita, K.; Mochiduki, Y.; Takizawa, N.; Yamanaka, S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26(1):101-106; 2008.
77. Nelson, T. J.; Martinez-Fernandez, A.; Yamada, S.; Perez- Terzic, C.; Ikeda, Y.; Terzic, A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120(5):408-416; 2009.
78. Noure, M. B.; Halpin, D. E.; Scatena, M.; Mortisen, D. J.; Tulloch, N. L.; Hauch, K. D.; Torok-Storb, B.; Ratner, B. D.; Pabon, L.; Murry, C. E. VEGF induces differentiation of functional endothelium from human embryonic stem cells: Implications for tissue engineering. Arterioscler. Thromb. Vasc. Biol. 30(1):80-89; 2010.
79. Nygren, J. M.; Jovinge, S.; Breitbach, M.; Sawen, P.; Roll, W.; Hescheler, J.; Taneera, J.; Fleischmann, B. K.; Jacobsen, S. E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10(5):494-501; 2004.
80. Oh, H.; Bradfute, S. B.; Gallardo, T. D.; Nakamura, T.; Gaussin, V.; Mishina, Y.; Pocius, J.; Michael, L. H.; Behringer, R. R.; Garry, D. J.; Entman, M. L.; Schneider, M. D. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 100(21):12313-12318; 2003.
81. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322(5903):949-953; 2008.
82. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S. M.; Li, B.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410(6829):701-705; 2001.
83. Ott, H. C.; Matthiesen, T. S.; Goh, S. K.; Black, L. D.; Kren, S. M.; Netoff, T. I.; Taylor, D. A. Perfusiondecellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat. Med. 14(2):213-221; 2008.
84. Pfannkuche, K.; Liang, H.; Hannes, T.; Xi, J.; Fatima, A.; Nguemo, F.; Matzkies, M.; Wernig, M.; Jaenisch, R.; Pillekamp, F.; Halbach, M.; Schunkert, H.; Sarić, T.; Hescheler, J.; Reppel, M. Cardiac myocytes derived from murine reprogrammed fibroblasts: Intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell. Physiol. Biochem. 24(1-2):73-86; 2009.
85. Pijnappels, D. A.; Schalij, M. J.; Ramkisoensing, A. A.; van Tuyn, J.; de Vries, A. A.; van der Laarse, A.; Ypey, D. L.; Atsma, D. E. Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Circ. Res. 103(2):167-176; 2008.
86. Pittenger, M. F.; Martin, B. J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95(1):9-20; 2004.
87. Robey, T. E.; Saiget, M. K.; Reinecke, H.; Murry, C. E. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 45(4):567-581; 2008.
88. Rosamond, W.; Flegal, K.; Friday, G.; Furie, K.; Go, A.; Greenlund, K.; Haase, N.; Ho, M.; Howard, V.; Kissela, B.; Kittner, S.; Lloyd-Jones, D.; McDermott, M.; Meigs, J.; Moy, C.; Nichol, G.; O'Donnell, C. J.; Roger, V.; Rumsfeld, J.; Sorlie, P.; Steinberger, J.; Thom, T.; Wasserthiel-Smoller, S.; Hong, Y. Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115(5):e69-171; 2007.
89. Rose, R. A.; Jiang, H.; Wang, X.; Helke, S.; Tsoporis, J. N.; Gong, N.; Keating, S. C.; Parker, T. G.; Backx, P. H.; Keating, A. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells 26(11):2884-2892; 2008.
90. Roy, S.; Silacci, P.; Stergiopulos, N. Biomechanical properties of decellularized porcine common carotid arteries. Am. J. Physiol. Heart Circ. Physiol. 289(4):H1567-1576; 2005.
91. Sasaki, K.; Heeschen, C.; Aicher, A.; Ziebart, T.; Honold, J.; Urbich, C.; Rossig, L.; Koehl, U.; Koyanagi, M.; Mohamed, A.; Brandes, R. P.; Martin, H.; Zeiher, A. M.; Dimmeler, S. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc. Natl. Acad. Sci. USA 103(39):14537-14541; 2006.
92. Schabort, E. J.; Myburgh, K. H.; Wiehe, J. M.; Torzewski, J.; Niesler, C. U. Potential myogenic stem cell populations: Sources, plasticity, and application for cardiac repair. Stem Cells Dev. 18(6):813-830; 2009.
93. Schachinger, V.; Erbs, S.; Elsasser, A.; Haberbosch, W.; Hambrecht, R.; Holschermann, H.; Yu, J.; Corti, R.; Mathey, D. G.; Hamm, C. W.; Süselbeck, T.; Werner, N.; Haase, J.; Neuzner, J.; Germing, A.; Mark, B.; Assmus, B.; Tonn, T.; Dimmeler, S.; Zeiher, A. M. Improved clinical outcome after intracoronary administration of bonemarrow- derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. Eur. Heart J. 27(23):2775-2783; 2006.
94. Segers, V. F.; Lee, R. T. Stem-cell therapy for cardiac disease. Nature 451(7181):937-942; 2008.
95. Shake, J. G.; Gruber, P. J.; Baumgartner, W. A.; Senechal, G.; Meyers, J.; Redmond, J. M.; Pittenger, M. F.; Martin, B. J. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann. Thorac. Surg. 73(6):1919-1925; discussion 1926; 2002.
96. Shimizu, T.; Yamato, M.; Isoi, Y.; Akutsu, T.; Setomaru, T.; Abe, K.; Kikuchi, A.; Umezu, M.; Okano, T. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ. Res. 90(3):e40-e48; 2002.
97. Smart, N.; Bollini, S.; Dube, K. N.; Vieira, J. M.; Zhou, B.; Davidson, S.; Yellon, D.; Riegler, J.; Price, A. N.; Lythgoe, M. F.; Pu, W. T.; Riley, P. R. De novo cardiomyocytes from within the activated adult heart after injury. Nature 474(7353):640-644; 2011.
98. Smart, N.; Risebro, C. A.; Melville, A. A.; Moses, K.; Schwartz, R. J.; Chien, K. R.; Riley, P. R. Thymosin b4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445(7124):177-182; 2007.
99. Smith, R. R.; Barile, L.; Cho, H. C.; Leppo, M. K.; Hare, J. M.; Messina, E.; Giacomello, A.; Abraham, M. R.; Marban, E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115(7):896-908; 2007.
100. Spyridopoulos, I.; Haendeler, J.; Urbich, C.; Brummendorf, T. H.; Oh, H.; Schneider, M. D.; Zeiher, A. M.; Dimmeler, S. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 110(19):3136-3142; 2004.
101. Stamm, C.; Nasseri, B.; Choi, Y. H.; Hetzer, R. Cell therapy for heart disease: Great expectations, as yet unmet. Heart Lung Circ. 18(4):245-256; 2009.
102. Strauer, B. E.; Yousef, M.; Schannwell, C. M. The acute and long-term effects of intracoronary stem cell transplantation in 191 patients with chronic heARt failure: The STAR-heart study. Eur. J. Heart Fail. 12(7):721-729; 2010.
103. Stubbs, S. L.; Crook, J. M.; Morrison, W. A.; Newcomb, A. E. Toward clinical application of stem cells for cardiac regeneration. Heart Lung Circ. 20(3):173-179; 2011.
104. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663-676; 2006.
105. Tambara, K.; Sakakibara, Y.; Sakaguchi, G.; Lu, F.; Premaratne, G. U.; Lin, X.; Nishimura, K.; Komeda, M. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation 108 Suppl 1:II259-263; 2003.
106. Tan, M. Y.; Zhi, W.; Wei, R. Q.; Huang, Y. C.; Zhou, K. P.; Tan, B.; Deng, L.; Luo, J. C.; Li, X. Q.; Xie, H. Q.; Yang, Z. M. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 30(19):3234-3240; 2009.
107. Taylor, D. A.; Atkins, B. Z.; Hungspreugs, P.; Jones, T. R.; Reedy, M. C.; Hutcheson, K. A.; Glower, D. D.; Kraus, W. E. Regenerating functional myocardium: Improved performance after skeletal myoblast transplantation. Nat. Med. 4(8):929-933; 1998.
108. Taylor, D. A.; Robertson, M. J. The basics of cell therapy to treat cardiovascular disease: One cell does not fit all. Rev. Esp. Cardiol. 62(9):1032-1044; 2009.
109. Terrovitis, J.; Lautamaki, R.; Bonios, M.; Fox, J.; Engles, J. M.; Yu, J.; Leppo, M. K.; Pomper, M. G.; Wahl, R. L.; Seidel, J.; Tsui, B. M.; Bengel, F. M.; Abraham, M. R.; Marbán, E. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J. Am. Coll. Cardiol. 54(17):1619-1626; 2009.
110. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145-1147; 1998.
111. Toma, C.; Pittenger, M. F.; Cahill, K. S.; Byrne, B. J.; Kessler, P. D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105(1):93-98; 2002.
112. Tomita, S.; Li, R. K.; Weisel, R. D.; Mickle, D. A.; Kim, E. J.; Sakai, T.; Jia, Z. Q. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100(19 Suppl):II247-256; 1999.
113. Traverse, J. H.; Henry, T. D.; Vaughan, D. E.; Ellis, S. G.; Pepine, C. J.; Willerson, J. T.; Zhao, D. X.; Piller, L. B.; Penn, M. S.; Byrne, B. J.; Perin, E. C.; Gee, A. P.; Hatzopoulos, A. K.; McKenna, D. H.; Forder, J. R.; Taylor, D. A.; Cogle, C. R.; Olson, R. E.; Jorgenson, B. C.; Sayre, S. L.; Vojvodic, R. W.; Gordon, D. J.; Skarlatos, S. I.; Moye', L. A.; Simari, R. D.; Cardiovascular Cell Therapy Research Network (CCTRN). Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am. Heart J. 158(3):356-363; 2009.
114. van Tuyn, J.; Atsma, D. E.; Winter, E. M.; van der Veldevan Dijke, I.; Pijnappels, D. A.; Bax, N. A.; Knaan- Shanzer, S.; Gittenberger-de Groot, A. C.; Poelmann, R. E.; van der Laarse, A.; van der Wall, E. E.; Schalij, M. J.; de Vries, A. A. Epicardial cells of human adults can undergo an epithelial-to-mesenchymal transition and obtain characteristics of smooth muscle cells in vitro. Stem Cells 25(2):271-278; 2007.
115. Velagaleti, R. S.; Pencina, M. J.; Murabito, J. M.; Wang, T. J.; Parikh, N. I.; D'Agostino, R. B.; Levy, D.; Kannel, W. B.; Vasan, R. S. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 118(20):2057-2062; 2008.
116. Vunjak-Novakovic, G.; Tandon, N.; Godier, A.; Maidhof, R.; Marsano, A.; Martens, T. P.; Radisic, M. Challenges in cardiac tissue engineering. Tissue Eng. Part B Rev. 16(2):169-187; 2010.
117. Weir, R. A.; McMurray, J. J.; Velazquez, E. J. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: Prevalence, clinical characteristics, and prognostic importance. Am. J. Cardiol. 97(10A):13F-25F; 2006.
118. Williams, A. R.; Trachtenberg, B.; Velazquez, D. L.; McNiece, I.; Altman, P.; Rouy, D.; Mendizabal, A. M.; Pattany, P. M.; Lopera, G. A.; Fishman, J.; Zambrano, J. P.; Heldman, A. W.; Hare, J. M. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: Functional recovery and reverse remodeling. Circ. Res. 108(7):792-796; 2011.
119. Wollert, K. C.; Drexler, H. Clinical applications of stem cells for the heart. Circ. Res. 96(2):151-163; 2005.
120. Wu, J.; Zeng, F.; Weisel, R. D.; Li, R. K. Stem cells for cardiac regeneration by cell therapy and myocardial tissue engineering. Adv. Biochem. Eng. Biotechnol. 114:107-128; 2009.
121. Wu, K. H.; Liu, Y. L.; Zhou, B.; Han, Z. C. Cellular therapy and myocardial tissue engineering: The role of adult stem and progenitor cells. Eur. J. Cardiothorac. Surg. 30(5):770-781; 2006.
122. Wu, S. M.; Chien, K. R.; Mummery, C. Origins and fates of cardiovascular progenitor cells. Cell 132(4):537-543; 2008.
123. Yang, Y.; Min, J. Y.; Rana, J. S.; Ke, Q.; Cai, J.; Chen, Y.; Morgan, J. P.; Xiao, Y. F. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J. Appl. Physiol. 93(3):1140-1151; 2002.
124. Yau, T. M.; Kim, C.; Ng, D.; Li, G.; Zhang, Y.; Weisel, R. D.; Li, R. K. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann. Thorac. Surg. 80(5):1779-1786; 2005.
125. Yoon, Y. S.; Park, J. S.; Tkebuchava, T.; Luedeman, C.; Losordo, D. W. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109(25):3154-3157; 2004.
126. Yousef, M.; Schannwell, C. M.; Kostering, M.; Zeus, T.; Brehm, M.; Strauer, B. E. The BALANCE Study: Clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 53(24):2262-2269; 2009.
127. Yu, J.; Hu, K.; Smuga-Otto, K.; Tian, S.; Stewart, R.; Slukvin, II; Thomson, J. A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324(5928):797-801; 2009.
128. Yu, J.; Vodyanik, M. A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J. L.; Tian, S.; Nie, J.; Jonsdottir, G. A.; Ruotti, V.; Stewart, R.; Slukvin, I. I.; Thomson, J. A. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858):1917-1920; 2007.
129. Yuasa, S.; Fukuda, K. Cardiac regenerative medicine. Circ. J. 72(Suppl A):A49-55; 2008.
130. Zhang, J.; Wilson, G. F.; Soerens, A. G.; Koonce, C. H.; Yu, J.; Palecek, S. P.; Thomson, J. A.; Kamp, T. J. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ. Res. 104(4):e30-41; 2009.
131. Zhang, M.; Methot, D.; Poppa, V.; Fujio, Y.; Walsh, K.; Murry, C. E. Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33(5):907-921; 2001.
132. Zhou, B.; Ma, Q.; Rajagopal, S.; Wu, S. M.; Domian, I.; Rivera-Feliciano, J.; Jiang, D.; von Gise, A.; Ikeda, S.; Chien, K. R.; Pu, W. T. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454(7200):109-113; 2008.
133. Zimmermann, W. H.; Fink, C.; Kralisch, D.; Remmers, U.; Weil, J.; Eschenhagen, T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 68(1):106-114; 2000.